23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
The Workers’ Minimum Standard of Housing and Amenities (Amendment) Act 2019 aims to expand the mini...
Read More >
SUPREME COURT HEARS DACA ARGUMENTS - On November 12, 2019, the U.S. Supreme Court heard almost 90 m...
Read More >
On October 16, 2020, the Securities and Exchange Commission ("SEC") adopted amendments to certain au...
Read More >
On Feb. 19, 2020, the SEC announced charges against Diageo plc, an alcoholic beverages company, aris...
Read More >
It was a close call, but a court recently denied an employee’s Americans with Disabilities Act clai...
Read More >
As part of the 2020 appropriations act, Congress passed the SECURE Act (Setting Every Community Up f...
Read More >